Literature DB >> 27381365

A Gestalt approach to Gram-negative entry.

Lynn L Silver1.   

Abstract

A major obstacle confronting the discovery and development of new antibacterial agents to combat resistant Gram-negative (GN) organisms is the lack of a rational process for endowing compounds with properties that allow (or promote) entry into the bacterial cytoplasm. The major permeability difference between GN and Gram-positive (GP) bacteria is the GN outer membrane (OM) which is a permeability barrier itself and potentiates efflux pumps that expel compounds. Based on the fact that OM-permeable and efflux-deleted GNs are sensitive to many anti-GP drugs, recent efforts to approach the GN entry problem have focused on ways of avoiding efflux and transiting or compromising the OM, with the tacit assumption that this could allow entry of compounds into the GN cytoplasm. But bypassing the OM and efflux obstacles does not take into account the additional requirement of penetrating the cytoplasmic membrane (CM) whose sieving properties appear to be orthogonal to that of the OM. That is, tailoring compounds to transit the OM may well compromise their ability to enter the cytoplasm. Thus, a Gestalt approach to understanding the chemical requirements for GN entry seems a useful adjunct. This might consist of characterizing compounds which reach the cytoplasm, grouping (or binning) by routes of entry and formulating chemical 'rules' for those bins. This will require acquisition of data on large numbers of compounds, using non-activity-dependent methods of measuring accumulation in the cytoplasm. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial agents; Binning; Gram-negative entry; Physicochemical characteristics

Mesh:

Substances:

Year:  2016        PMID: 27381365     DOI: 10.1016/j.bmc.2016.06.044

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  49 in total

1.  Spectrofluorimetric quantification of antibiotic drug concentration in bacterial cells for the characterization of translocation across bacterial membranes.

Authors:  Julia Vergalli; Estelle Dumont; Jelena Pajović; Bertrand Cinquin; Laure Maigre; Muriel Masi; Matthieu Réfrégiers; Jean-Marie Pagés
Journal:  Nat Protoc       Date:  2018-05-17       Impact factor: 13.491

2.  Translocation of small molecules through engineered outer-membrane channels from Gram-negative bacteria.

Authors:  Rémi Terrasse; Mathias Winterhalter
Journal:  Eur Phys J E Soft Matter       Date:  2018-09-24       Impact factor: 1.890

3.  Synthesis and Biological Evaluation of the Antimicrobial Natural Product Lipoxazolidinone A.

Authors:  Jonathan J Mills; Kaylib R Robinson; Troy E Zehnder; Joshua G Pierce
Journal:  Angew Chem Int Ed Engl       Date:  2018-06-10       Impact factor: 15.336

4.  Expanded Structure-Activity Studies of Lipoxazolidinone Antibiotics.

Authors:  Kaylib R Robinson; Jonathan J Mills; Joshua G Pierce
Journal:  ACS Med Chem Lett       Date:  2019-02-28       Impact factor: 4.345

Review 5.  Defining new chemical space for drug penetration into Gram-negative bacteria.

Authors:  Shibin Zhao; Justyna W Adamiak; Vincent Bonifay; Jitender Mehla; Helen I Zgurskaya; Derek S Tan
Journal:  Nat Chem Biol       Date:  2020-11-16       Impact factor: 15.040

Review 6.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Authors:  Ronald Domalaon; Temilolu Idowu; George G Zhanel; Frank Schweizer
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

7.  Predictive compound accumulation rules yield a broad-spectrum antibiotic.

Authors:  Michelle F Richter; Bryon S Drown; Andrew P Riley; Alfredo Garcia; Tomohiro Shirai; Riley L Svec; Paul J Hergenrother
Journal:  Nature       Date:  2017-05-10       Impact factor: 49.962

8.  Short Proline-Rich Lipopeptide Potentiates Minocycline and Rifampin against Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa.

Authors:  Ronald Domalaon; Yaroslav Sanchak; Linet Cherono Koskei; Yinfeng Lyu; George G Zhanel; Gilbert Arthur; Frank Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 9.  Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.

Authors:  Bikash Baral; M R Mozafari
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-13

10.  Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa.

Authors:  Connor J Cooper; Ganesh Krishnamoorthy; David Wolloscheck; John K Walker; Valentin V Rybenkov; Jerry M Parks; Helen I Zgurskaya
Journal:  ACS Infect Dis       Date:  2018-05-25       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.